We aim to minimize permanent loss and compound capital at above-market returns over the long run.
8 letters, 2025 to 2026
| i | ||||||
|---|---|---|---|---|---|---|
| Protasco | Named in letters | 4 | ||||
| Ascentech | Named in letters | 3 | ||||
| Claranova | CLA | Named in letters | 3 | |||
| Grupo Empresarial San José | GSJ | Named in letters | 3 | |||
| FinVolution | NYSE: FINV | Named in letters | 2 | |||
| Marex | Named in letters | 2 | ||||
| Able Engineering Holdings | Named in letters | 1 | ||||
| Named in letters | 1 | |||||
| Named in letters | Conglomerates | $1.21T | 1 | |||
| Chien Kuo Construction | Named in letters | 1 | ||||
| Named in letters | 1 | |||||
| Collegium Pharmaceutical | Nasdaq: COLL | Named in letters | 1 | |||
| Named in letters | Insurance, payments and financial services | Acquired | 1 | |||
| Named in letters | 1 | |||||
| Named in letters | 1 |
| Q3 2026 Letter to Partners: Pitch, Know, Invest | Marcel Gozali argues that pitching, knowing and investing are separate skills, citing an AI fund run by a former OpenAI researcher that lost 67% in July on 4x gross exposure, and buys Chien Kuo Construction, whose investment portfolio covers about 80% of its market value. | Q3 2026 | 2026-10-08 | Marex, Protasco, Ascentech, Chien Kuo Construction, OpenAI, Anthropic |
| Q2 2026 Letter to Partners: Risk Before Reward | Marcel Gozali argues that the hyperscalers' AI arms race needs $500 billion to $1 trillion of new revenue to earn 10% on $1 trillion of 2027 capex, and that low expectations make unpopular stocks such as Marex, a non-bank clearing firm, the safer buy. | Q2 2026 | 2026-07-03 | Marex, Ascentech, Protasco, Goldman Sachs |
| Q1 2026 Letter to Partners: The Proteus Test | Marcel Gozali argues that investors should hold positions through volatility from wars, energy disruptions and AI fears as long as the thesis stands, as with Protasco at 1.3x trailing earnings and Ascentech, whose infrastructure software he expects AI adoption to need more of. | Q1 2026 | 2026-04-03 | Ascentech, Protasco, Citrix |
| Updated: JetBlue Put Options Rise as Structural Risk Gains Recognition | Q4 2025 | 2025-12-30 | ||
| Q3 2025 Letter to Partners: Aristotle’s Advice | Marcel Gozali argues that investors need Aristotle's practical wisdom to act when facts change, explains why he sold FinVolution and Claranova, and buys Able Engineering at 6x earnings and Protasco, whose land bank he values at its whole market value. | Q3 2025 | 2025-10-09 | FinVolution, Claranova, Grupo Empresarial San José, Able Engineering Holdings, Protasco |
| Q2 2025 Letter to Partners: My Short Tribute to Warren Buffett | Marcel Gozali marks Warren Buffett's retirement as Berkshire Hathaway's CEO by drawing from his quotes that investors must think for themselves and seek disconfirming evidence, and reports that FinVolution offers about a 30% free cash flow yield. | Q2 2025 | 2025-07-07 | Berkshire Hathaway, GEICO, Grupo Empresarial San José, Claranova, FinVolution |
| Q1 2025 Letter to Partners: Insist on the Most Knowable | Marcel Gozali argues that an investor should buy only stocks that can be known and that rise in many versions of the future, such as Grupo Empresarial San José, whose net cash about equals its €370 million market value. | Q1 2025 | 2025-04-09 | Grupo Empresarial San José, Claranova, Collegium Pharmaceutical |
| Wild or zoo: 2025 letter to partners | 2025 |